Biotech News

Precipio Announces Q3-2026 Financial Results

Precipio Diagnostics (PRPO)Precipio DiagnosticsEarnings

Record quarterly revenue, positive Adjusted EBITDA, and strong operating cash flow - all position Precipio for accelerated future growth Record quarterly revenue, positive Adjusted EBITDA, and strong operating cash flow - all position Precipio for accelerated future growth

Related news

Precipio Diagnostics

Cancer Diagnostics Company Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies. It develops testing approaches intended to improve diagnostic accuracy for physicians, laboratories, and patients. Integrated Clinical Laboratory The company operates its own clinical laboratory,...

Recent company news

Stock data

Close
18.49 USD
Market cap
40.18M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States